Elevated serum levels of interleukin-18 in patients with overt diabetic nephropathy: effects of miglitol. (Q51391705)

4 April 2018

title

Elevated serum levels of interleukin-18 in patients with overt diabetic nephropathy: effects of miglitol. (English)

1 reference

4 April 2018

1 reference

Takashi Uzu

1

1 reference

4 April 2018

Hiroki Yokoyama

2

1 reference

4 April 2018

Hirofumi Itoh

3

1 reference

4 April 2018

Daisuke Koya

4

1 reference

4 April 2018

Atsushi Nakagawa

5

1 reference

4 April 2018

Makoto Nishizawa

6

1 reference

4 April 2018

Hiroshi Maegawa

7

1 reference

4 April 2018

Yukiyo Yokomaku

8

1 reference

4 April 2018

Shin-Ichi Araki

9

1 reference

4 April 2018

Atsuko Abiko

10

1 reference

4 April 2018

Masakazu Haneda

11

1 reference

4 April 2018

publication date

9 September 2010

1 reference

4 April 2018

Clinical and experimental nephrology

published in

1 reference

4 April 2018

volume

15

1 reference

4 April 2018

issue

1

1 reference

4 April 2018

page(s)

58-63

1 reference

4 April 2018

https://scigraph.springernature.com/pub.10.1007/s10157-010-0343-7

exact match

0 references

cites work

Hyperglycemia and cardiovascular disease in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS10157-010-0343-7

Diabetes and atherosclerosis: epidemiology, pathophysiology, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-010-0343-7

Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-010-0343-7

Atherosclerosis — An Inflammatory Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-010-0343-7

Interleukin-18 (IFNgamma-inducing factor) induces IL-8 and IL-1beta via TNFalpha production from non-CD14+ human blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-010-0343-7

Interleukin-18, the metabolic syndrome, and subclinical atherosclerosis: results from the Dallas Heart Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-010-0343-7

Interleukin-18 and the risk of future cardiovascular disease among initially healthy women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-010-0343-7

Serum interleukin-18 levels are associated with nephropathy and atherosclerosis in Japanese patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-010-0343-7

Predictive impact of elevated serum level of IL-18 for early renal dysfunction in type 2 diabetes: an observational follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-010-0343-7

Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-010-0343-7

International Diabetes Federation guideline for management of postmeal glucose: a review of recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-010-0343-7

Elevated plasma interleukin-18 is a marker of insulin-resistance in type 2 diabetic and non-diabetic humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-010-0343-7

Low-grade inflammation, obesity, and insulin resistance in adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-010-0343-7

Serum IL-18 levels in patients with type 1 diabetes: relations to metabolic control and microvascular complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-010-0343-7

Revised equations for estimated GFR from serum creatinine in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-010-0343-7

Diabetes, hypertension, and cardiovascular disease: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-010-0343-7

Associations of circulating TNFalpha and IL-18 with myocardial infarction and cardiovascular risk markers: the Glasgow Myocardial Infarction Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-010-0343-7

Endoplasmic reticulum stress and renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-010-0343-7

Biochemistry and molecular cell biology of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-010-0343-7

IL-18 regulates IL-1beta-dependent hepatic melanoma metastasis via vascular cell adhesion molecule-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-010-0343-7

Interleukin-18 levels are associated with low-density lipoproteins size.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-010-0343-7

IL-18 is involved in vascular injury in end-stage renal disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-010-0343-7

Standards of medical care in diabetes--2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-010-0343-7

Increase in plasma endotoxin concentrations and the expression of Toll-like receptors and suppressor of cytokine signaling-3 in mononuclear cells after a high-fat, high-carbohydrate meal: implications for insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-010-0343-7

Miglitol suppresses the postprandial increase in interleukin 6 and enhances active glucagon-like peptide 1 secretion in viscerally obese subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-010-0343-7

Effects of S21403 (mitiglinide) on postprandial generation of oxidative stress and inflammation in type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-010-0343-7

Increased interleukin-18 content and angiogenic activity of sera from diabetic (Type 2) patients with background retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-010-0343-7

Expression of Interleukin-18 in Human Atherosclerotic Plaques and Relation to Plaque Instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-010-0343-7

Inflammation, stress, and diabetes

21 January 2018

1 reference

12 December 2020

Reducing cardiovascular risk in type 2 diabetes

1 reference

12 December 2020

Management of drugs affecting blood glucose in diabetic patients with renal failure.

1 reference

12 December 2020

Pharmacokinetics of miglitol. Absorption, distribution, metabolism, and excretion following administration to rats, dogs, and man.

1 reference

12 December 2020

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

1 reference

12 December 2020

Dietary fatty acids affect plasma markers of inflammation in healthy men fed controlled diets: a randomized crossover study.

1 reference

12 December 2020

10.1007/S10157-010-0343-7

Identifiers

DOI

1 reference

4 April 2018

PubMed ID

20824296

1 reference

4 April 2018